Jiangsu Jibeier Pharmaceutical Management
Management criteria checks 3/4
Jiangsu Jibeier Pharmaceutical's CEO is Zhongyi Geng, appointed in Sep 2014, has a tenure of 10.25 years. directly owns 12.68% of the company’s shares, worth CN¥563.39M. The average tenure of the management team and the board of directors is 10.3 years and 6.6 years respectively.
Key information
Zhongyi Geng
Chief executive officer
CN¥1.5m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.3yrs |
| CEO ownership | 12.7% |
| Management average tenure | 10.3yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
Jiangsu Jibeier Pharmaceutical's (SHSE:688566) Solid Earnings May Rest On Weak Foundations
Nov 06
Even With A 38% Surge, Cautious Investors Are Not Rewarding Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Performance Completely
Oct 08Does Jiangsu Jibeier Pharmaceutical (SHSE:688566) Deserve A Spot On Your Watchlist?
Oct 01Jiangsu Jibeier Pharmaceutical Co., Ltd.'s (SHSE:688566) Shares Lagging The Market But So Is The Business
Jul 30Impressive Earnings May Not Tell The Whole Story For Jiangsu Jibeier Pharmaceutical (SHSE:688566)
May 02CEO
Zhongyi Geng (61 yo)
10.3yrs
Tenure
CN¥1,454,700
Compensation
Mr. Zhongyi Geng serves as the Chairman of the Board at Jiangsu Jibeier Pharmaceutical Co., Ltd. since November 2001 and serves as its General Manager since September 25, 2014. He also serves as core Techn...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 10.3yrs | CN¥1.45m | 12.68% CN¥ 563.4m | |
| Vice Chairman of the Board & Deputy GM | 23.1yrs | CN¥822.70k | 0.042% CN¥ 1.9m | |
| Financial Director | 7.6yrs | CN¥746.90k | 0.070% CN¥ 3.1m | |
| Equipment Director & Director | no data | CN¥752.60k | 0.042% CN¥ 1.9m | |
| Chief Engineer & Deputy GM | 10.3yrs | CN¥756.30k | 0.042% CN¥ 1.9m | |
| Board Secretary | 10.3yrs | CN¥746.90k | 0.070% CN¥ 3.1m | |
| Deputy Director of the Research Institute | no data | CN¥382.30k | 0.024% CN¥ 1.1m | |
| Deputy Director of the Research Institute | no data | CN¥309.50k | 0.024% CN¥ 1.1m | |
| Director of the Synthesis Office of the Research Institute | no data | CN¥403.10k | 0.024% CN¥ 1.1m | |
| Institute Director | no data | CN¥656.10k | no data |
10.3yrs
Average Tenure
57yo
Average Age
Experienced Management: 688566's management team is seasoned and experienced (10.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 23.1yrs | CN¥1.45m | 12.68% CN¥ 563.4m | |
| Vice Chairman of the Board & Deputy GM | 23.1yrs | CN¥822.70k | 0.042% CN¥ 1.9m | |
| Equipment Director & Director | 4.3yrs | CN¥752.60k | 0.042% CN¥ 1.9m | |
| Independent Director | 6.6yrs | CN¥100.00k | no data | |
| Independent Director | 6.6yrs | CN¥100.00k | no data | |
| Director | 10.3yrs | no data | 6.99% CN¥ 310.8m | |
| Chairman of the Supervisory Board | 4.3yrs | no data | no data | |
| Employee Representative Supervisor | 4.3yrs | no data | no data |
6.6yrs
Average Tenure
53yo
Average Age
Experienced Board: 688566's board of directors are considered experienced (6.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 10:31 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Jibeier Pharmaceutical Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Song Yang | Tianfeng Securities Brokerage Co., Ltd |
| Tielin Chen | Topsperity Securities |
| Xinming Zhou | Topsperity Securities |